COMMUNIQUÉS West-GlobeNewswire

Erisyon Awarded $2.2M Grant to Develop Diagnostic for Immuno-Oncology Treatment Selection

07/01/2025 - 14:00

AUSTIN, Texas, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Erisyon, a leading provider of single-molecule proteomics technology, today announced that it has been awarded a $2.2 million grant from the Cancer Prevention and [...]

Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism

07/01/2025 - 14:00

Breakthrough Therapy Designation granted based on key positive data from the Phase 2b (RIZE) study and current unmet medical need in congenital hyperinsulinism (HI) Ersodetug continues to advance in clinical development [...]

Korro to Present at the 43rd Annual J.P. Morgan Healthcare Conference

07/01/2025 - 14:00

CAMBRIDGE, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both [...]

Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2024 Financial Results on February 10, 2025

07/01/2025 - 14:00

MINNEAPOLIS, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and fiscal 2024 after the close of trading on Monday, February 10 [...]

DiagnaMed Partners with Texas Tech University to Pioneer Hydrogen Innovation

07/01/2025 - 14:00

TORONTO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a leading innovator in hydrogen-producing technologies and artificial intelligence (AI) [...]

Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit

07/01/2025 - 14:00

CUPERTINO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet [...]

Annexon Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

07/01/2025 - 14:00

BRISBANE, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical [...]

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

07/01/2025 - 14:00

MONTREAL and CHARLOTTE, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today announced that the Company granted equity awards, in the form of a [...]

Grace Therapeutics to Participate in Upcoming Investor Events January 2025

07/01/2025 - 14:00

PRINCETON, N.J., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) formerly Acasti Pharma Inc. (Nasdaq: ACST) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx- [...]

RESTEM Receives FDA Fast Track Designation for Restem-L for Idiopathic Inflammatory Myopathy

07/01/2025 - 14:00

• Second regulatory designation for Restem-L, a lead ULSC program, following the recent Orphan Drug Designation • Recently reported Phase 1 data of Restem-L demonstrated a clinically meaningful efficacy and significant [...]

Raphael Pharmaceutical Announces Positive Proof-of-Concept Clinical Study Results for the Company’s Cannabinoid-Based Formula for the Treatment of Rheumatoid Arthritis

07/01/2025 - 14:00

* Patients in Study Reported Lower Pain Levels, Better Sleep Quality, and Improved Wellbeing * Disease Activity Score Decreased by 19.2%, Reflecting a Shift in Disease Activity from High to Moderate * More than 80% of [...]

Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

07/01/2025 - 14:05

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what [...]

Cytrellis Biosystems launches Updated Next-Generation Skin Removal Treatment ellacor® 2.0, fueled by new leadership and financing

07/01/2025 - 14:15

WOBURN, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Cytrellis Biosystems, Inc., a pioneer in novel medical aesthetic solutions, today announced the launch of the updated ellacor ® system, the first and only minimally [...]

QUANTRO Therapeutics achieves breakthrough in transcriptomic drug discovery with first successful simultaneous 10-target multiplex-screening

07/01/2025 - 14:30

QUANTRO’s proprietary time-resolved functional transcriptomic discovery platform accelerates target screening for complex indications in oncology and inflammation QUANTRO CEO Dr. Michael Bauer to attend Biotech Showcase [...]

Ori Biotech Announces First Customer Deliveries of IRO to Leading CDMOs and Commercial CGT Manufacturers

07/01/2025 - 14:30

Six months after its unveiling, the IRO platform is now being deployed to customers LONDON, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Oribiotech Ltd. (Ori), a leader in cell and gene therapy (CGT) manufacturing technology, [...]

Xenon to Present at the 43rd Annual J.P. Morgan Healthcare Conference

07/01/2025 - 14:30

VANCOUVER, British Columbia and BOSTON, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering [...]

Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission

07/01/2025 - 14:30

Over 300 Participants Have Completed Cumulative Six Months of Cytisinicline Treatment in the ORCA-OL Trial, Completing the Long-Term Exposure Requirement for NDA Submission ORCA-OL Long-Term Exposure Timelines Remain on [...]

CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents

07/01/2025 - 14:50

BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Tuesday, January 7th by OraSure Technologies, Inc. (NASDAQ: OSUR), please note that the first sentence of the release ( [...]

Sutro Biopharma and Boehringer Ingelheim BioXcellence™ collaboration: Established first-in-class cell-free capabilities at commercial scale

07/01/2025 - 15:00

SOUTH SAN FRANCISCO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Boehringer Ingelheim BioXcellence™ and Sutro Biopharma Inc. today announced that they successfully applied Sutro’s proprietary cell-free expression [...]